Physician profile
Jayanth Manoharan
NPI 1982022968
$4,469.50
in general payments reported to CMS, 2019-2025
15 companies · $88.37 in 2025
The $88.37 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $11.14 · 2021: $1,254 · 2022: $2,094 · 2023: $216 · 2024: $60.09 · 2025: $88.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,718.99 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $225.78 | 2019 | |
| Smith+Nephew, INC. | $132.42 | 2021-2025 | "Acticoat 4"" X 4""", Pico 7, Pico 14 |
| Takeda Pharmaceuticals U.S.A., INC. | $117.20 | 2021-2023 | Gattex |
| Tela Bio, INC. | $84.68 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Phathom Pharmaceuticals, INC. | $29.56 | 2024 | Voquezna |
| Innocoll Pharmaceuticals Limited | $26.08 | 2021-2022 | |
| Glaxosmithkline, LLC. | $20.65 | 2023 | Arexvy, Shingrix |
| Acacia Pharma INC | $20.25 | 2021 | |
| Exact Sciences Corporation | $18.15 | 2025 | Cologuard Collection Kit |
| Kerecis Limited | $16.61 | 2022 | |
| Medtronic, INC. | $16.28 | 2022 | |
| Merck Sharp & Dohme LLC | $16.06 | 2021 | |
| Amgen INC. | $15.65 | 2025 | Repatha, Otezla |
| Misonix INC | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayanth Manoharan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.